Success Metrics

Clinical Success Rate

71.4%

Based on 5 completed trials

Completion Rate

71%(5/7)

Active Trials

3(23%)

Results Posted

40%(2 trials)

Terminated

2(15%)

Phase Distribution

Ph not_applicable

15%

Ph phase_3

Ph phase_1

31%

Ph phase_2

31%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Phase 1Safety & dosage

4(36.4%)

Phase 2Efficacy & side effects

4(36.4%)

Phase 3Large-scale testing

1(9.1%)

N/ANon-phased studies

2(18.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(5)

Terminated(3)

Other(1)

Detailed Status

Completed5

Recruiting2

Terminated2

Withdrawn1

Enrolling by invitation1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

71.4%

Most Advanced

Phase 3

Trials by Phase

Phase 14 (36.4%)

Phase 24 (36.4%)

Phase 31 (9.1%)

N/A2 (18.2%)

Trials by Status

withdrawn18%

enrolling_by_invitation18%

recruiting215%

active_not_recruiting18%

terminated215%

unknown18%

completed538%

Recent Activity

3 active trials

Showing 5 of 13

enrolling_by_invitation

the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis

NCT03524352

recruitingphase_2

Stool Transplants to Treat Refractory Clostridium Difficile Colitis

NCT02127398

View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials

NCT07622849

FMT in Transplant-related Gastrointestinal Mucositis

Enrolling By Invitation

NCT03148743

FMT in Gut aGVHD Treated

Recruiting

NCT05917379Phase 1

The Efficacy and Safty of FMT in Patients With CID

Completed

NCT03524352Phase 3

the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis

Active Not Recruiting

NCT02127398Phase 2

Stool Transplants to Treat Refractory Clostridium Difficile Colitis

Recruiting

NCT03948919Phase 1

Fecal Transplant for Ulcerative Colitis

Completed

NCT02318992Phase 1

Fresh, Frozen or Lyophilized Fecal Microbiota Transplantation for Multiple Recurrent C. Difficile Associated Diarrhea

Completed

NCT04579263Not Applicable

Assessment of the Health Improvement of Obese Patients After Fecal Microbiota Transplantation (FMT)

Completed

NCT04434872Phase 2

Fecal Microbiota Transplantation as a Treatment for Ulcerative Colitis

Terminated

NCT03183869Phase 2

Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients

Terminated

NCT02256592Phase 1

Fecal Microbiota Transplantation in HIV

Completed

NCT02686645Phase 2

Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection

Unknown

NCT01842347Not Applicable

Treatment of C. Difficile Infection With Fecal Microbiota Transplantation (FMT)

Withdrawn

All 13 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 13